Medallion Wealth Advisors’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.6K Sell
169
-56
-25% -$5.62K 0.01% 695
2025
Q4
$23K Hold
225
0.01% 615
2025
Q3
$14.1K Hold
225
0.01% 699
2025
Q2
$11.4K Hold
225
﹤0.01% 723
2025
Q1
$9.55K Buy
+225
New +$9.71K ﹤0.01% 689

Other funds holding GH

Medallion Wealth Advisors's GH Position: Q1 2026 in Review

Medallion Wealth Advisors reduced its Guardant Health (GH) stake by 25% in Q1 2026, selling an estimated $5.62K and leaving 169 shares worth $15.6K. The position accounts for 0.01% of the portfolio, ranked #695.

Medallion Wealth Advisors first reported a position in GH in Q1 2025 and has held it in 5 quarters since. The position peaked at $23K in Q4 2025. 482 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Medallion Wealth Advisors held 169 shares of Guardant Health worth $15.6K as of Q1 2026.
  • Medallion Wealth Advisors sold 56 Guardant Health shares in Q1 2026, an estimated $5.62K.
  • Guardant Health made up 0.01% of Medallion Wealth Advisors's portfolio in Q1 2026, its #695 holding.
  • Medallion Wealth Advisors first reported a position in Guardant Health in Q1 2025 and has held it in 5 quarters since.
  • Medallion Wealth Advisors's Guardant Health position peaked at $23K in Q4 2025.
  • 482 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Medallion Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.